Funding for this research was provided by:
Takeda Pharmaceuticals U.S.A.
National Heart, Lung, and Blood Institute (T32HL007106)
Received: 27 July 2020
Accepted: 30 October 2020
First Online: 11 November 2020
Ethics approval and consent to participate
: Ethical approval of the study was provided by the institutional review boards of the University of North Carolina at Chapel Hill (16–2128), the Mbarara University of Science and Technology (01/03–16), and the Uganda National Council for Science and Technology (HS 2115). Written informed consent for participation in the study was obtained from all adult participants or from their parent or guardian when participants were children (under 18 years old).
: Not applicable.
: All authors have completed the ICMJE uniform disclosure form and declare: no financial relationships with any organisations that might have an interest in the submitted work in the previous 3 years; no other relationships or activities that could appear to have influenced the submitted work.